Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for levodopa-induced dyskinesia in Parkinson's disease
RBR-1047fwbfPhase 2Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of doxycycline in Parkinson's disease (PD), sponsored by Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto. Started Mar 2021; status: completed.
02
Drugs
doxycycline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on RBR-1047fwbf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-1047fwbf.